Essilor supports the Association of Malaysian Optometrists’ inaugural Global Orthokeratology and Myopia Control Conference
Jun 28, 2018

Kuala Lumpur, Malaysia, 27 June 2018 --( ASIA TODAY )-- Essilor the world’s leading ophthalmic optics company, is proud to be platinum sponsor of the inaugural Global Orthokeratology and Myopia Control Conference (GOMCC) organized by The Association of Malaysian Optometrists (AMO) and held at The Gardens in Kuala Lumpur. GOMCC is the first conference in Malaysia to focus on myopia control. The two-day conference presents international leading clinical and research minds in this area of specialty of the profession with the aim of bringing some 250 optometrists to the forefront of myopia management. Renowned speakers with expertise on myopia management from Australia, China, Germany, Italy, Malaysia, New Zealand, Singapore, Spain, Taiwan and United States will share their experience and best practices in managing their patients’ myopia progression with different solutions.

Essilor is committed to support AMO in its mission to equip the regional optometrists with the essential skill and knowledge to address the increasing prevalence of myopia among the young population. Dr Damien Paille, a member of Essilor’s optical research and development team will present his paper on “The Myopilux® range of spectacle lenses for myopia control”. Essilor will also be sharing its expertise in the area of myopic management at dedicated industrial sessions and workshops at the conference.

By 2050, it is estimated that half the world’s population, or close to 5 billion people, will be myopic[1]. Despite the epidemic size of the challenge, the science of myopia is still young and awareness low. Many people affected by myopia are unaware of what is available to correct and control it now, as well as reduce long-term risks, especially for high myopes who have a high probability of developing serious eye conditions and potentially losing their sight. Continuing to innovate solutions to correct and control myopia is integral to Essilor’s mission of improving lives by improving sight.

“As the world leader in the eye care industry, we believe it is the company’s responsibility to be the leading player in the management of myopia and offer a comprehensive range of solutions for children, teens and adults, to manage the evolution of myopia over their lifetime” commented Dr. John Ang, President, The International Vision Academy, Vice-President, Education & Professional Services, Essilor Asia-Pacific, Middle East, Russia, Africa. He continued, “Supporting and participating in this inaugural Global Orthokeratology and Myopia Control Conference is a further step in our drive to equip eye care professionals with the essential myopia management knowledge and skills to support myopic patients throughout their progression journey.”

In Malaysia, as in other parts of the world, there is an increasing number of children who are myopic when they reach 12 years old1. Not just a vision impairment or inconvenience that affects learning at school, playing sport or pursuing hobbies, it has long consequences as high myopia increases the risks of degenerative conditions such as retinal detachment, early cataract development, macular degeneration and glaucoma. These risks are not mitigated by refractive surgery.

The myopia epidemic presents significant implications for planning comprehensive eye care services globally, including managing and preventing myopia-related ocular complications and vision loss among almost those with high myopia. More recent studies indicate that myopic macular degeneration is becoming a serious issue, especially in East Asia, and is already one of the 3 leading causes of blindness.

Designations :
1. Dr. John Ang, President, The International Vision Academy, Vice-President, Education & Professional Services, Essilor Asia-Pacific, Middle East, Russia, Africa
2. Dr Damien Paille, Senior Vision Scientist, Centre for Innovation & Technology AMERA, Essilor R&D Centre Singaopore
3. Mr Woon Pak Seong, President for the Association of Malaysian Optometrists, Managing Director of Vision Space Sdn Bhd


About Essilor
Essilor International (Compagnie Générale d’Optique) (“Essilor”) is the world’s leading ophthalmic optics company. Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its mission is to improve lives by improving sight. To support this mission, Essilor allocates more than €200 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Its flagship brands are Varilux®, Crizal®, Transitions®, EyezenTM, Xperio®, Foster Grant®, BolonTM and Costa®. It also develops and markets equipment, instruments and services for eyecare professionals.
Essilor reported consolidated revenue of around €7.5 billion in 2017 and employs approximately 67,000 people worldwide.

It has 34 plants, 481 prescription laboratories and edging facilities, as well as 4 research and development centers around the world. For more information, please visit

The Essilor share trades on the Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices.

Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.

For media enquiries, please contact The Rainmaker Marketing Group Pte Ltd at 6475 8368.

Nalini Naidu
Malaysia mobile : +60 11 19541956
Singapore mobile & Whatsapp: +65 9633 3198

Dean Johari
mobile & Whatsapp : +65 9697 4464

Ong Yu Fan
mobile & Whatsapp: +65 9030 8619

- ASIA TODAY News Global Distribution